These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11525560)

  • 1. Gene therapy for rheumatoid arthritis.
    Burstein H
    Curr Opin Mol Ther; 2001 Aug; 3(4):362-74. PubMed ID: 11525560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model.
    Müller-Ladner U; Evans CH; Franklin BN; Roberts CR; Gay RE; Robbins PD; Gay S
    Arthritis Rheum; 1999 Mar; 42(3):490-7. PubMed ID: 10088772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
    Neumann E; Judex M; Kullmann F; Grifka J; Robbins PD; Pap T; Gay RE; Evans CH; Gay S; Schölmerich J; Müller-Ladner U
    Gene Ther; 2002 Nov; 9(22):1508-19. PubMed ID: 12407423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy in rheumatic diseases.
    Vervoordeldonk MJ; Tak PP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.
    Yamamoto A; Fukuda A; Seto H; Miyazaki T; Kadono Y; Sawada Y; Nakamura I; Katagiri H; Asano T; Tanaka Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2003 Sep; 48(9):2682-92. PubMed ID: 13130489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
    Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis.
    Denys A; Thiolat A; Descamps D; Lemeiter D; Benihoud K; Bessis N; Boissier MC
    J Gene Med; 2010 Aug; 12(8):659-68. PubMed ID: 20623491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications for interferon-alpha in arthritis: a pilot study.
    Wong T; Majchrzak B; Bogoch E; Keystone EC; Fish EN
    J Rheumatol; 2003 May; 30(5):934-40. PubMed ID: 12734885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
    Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ
    Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene therapy in rheumatoid arthritis: new aspects].
    Pundt N; Peters MA; Wunrau C; Pap T
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1737-41. PubMed ID: 18696407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for rheumatoid arthritis.
    Bessis N; Doucet C; Cottard V; Douar AM; Firat H; Jorgensen C; Mezzina M; Boissier MC
    J Gene Med; 2002; 4(6):581-91. PubMed ID: 12439850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts.
    Kubota A; Hasegawa K; Suguro T; Koshihara Y
    J Rheumatol; 2004 Mar; 31(3):426-35. PubMed ID: 14994384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).
    Ruschpler P; Stiehl P
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):285-93. PubMed ID: 12030433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.